Eli Lilly and Co., down $18.92 to $189.16. Investors were disappointed by results from the drug developer’s study on a potential Alzheimer’s disease therapy. United States Steel Corp., down $1 ...

Eli Lilly’s shares have outperformed the Zacks ... (You can read the full research report on Thermo Fisher here >>>) Steel Partners’ shares have outperformed the Zacks Diversified Operations ...